Site-specific methylation of placental HSD11B2 gene promoter is related to intrauterine growth restriction

European Journal of Human Genetics

Volumn 22, Issue 6, 2014, Pages 734-740

  Zhao, Yan ^a   Gong, Xia ^b   Chen, Li ^a   Li, Luxi ^a   Liang, Yuan ^c   Chen, Shangqin ^c   Zhang, Yunhui ^a  

^a FUDAN UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

^c WENZHOU MEDICAL UNIVERSITY   (China)

Author keywords

birth weight; DNA methylation; HSD11B2; IUGR; placenta

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE 2; MESSENGER RNA; HSD11B2 PROTEIN, HUMAN;

ANTHROPOMETRIC PARAMETERS; ARTICLE; BIRTH WEIGHT; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; FEMALE; FETUS GROWTH; GENE EXPRESSION; GENETIC ANALYSIS; GENETIC ASSOCIATION; HUMAN; INTRAUTERINE GROWTH RETARDATION; MALE; NEWBORN; PLACENTA; PRIORITY JOURNAL; PROMOTER REGION; WEIGHT INDEX; WEIGHT REDUCTION; ADULT; DNA SEQUENCE; EMBRYOLOGY; GENE EXPRESSION REGULATION; GENETICS; GESTATIONAL AGE; MATERNAL AGE; METABOLISM; PATERNAL AGE; PREGNANCY; PROCEDURES; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; YOUNG ADULT;

11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 2; ADULT; BIRTH WEIGHT; CPG ISLANDS; DNA METHYLATION; FEMALE; FETAL GROWTH RETARDATION; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; MALE; MATERNAL AGE; PATERNAL AGE; PLACENTA; PREGNANCY; PROMOTER REGIONS, GENETIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA; YOUNG ADULT;

EID: 84901070429     PISSN: 10184813     EISSN: 14765438     Source Type: Journal    
DOI: 10.1038/ejhg.2013.226     Document Type: Article

References (31)

1. Wollmann HA: Intrauterine growth restriction: definition and etiology. Horm Res 1998; 49(Suppl 2): 1-6.
2. Alexander GR, Kogan M, Bader D, Carlo W, Allen M, Mor J: US birth weight/gestational age-specific neonatal mortality: 1995-1997 rates for whites, hispanics, and blacks. Pediatrics 2003; 111: e61-e66.
3. Baschat AA: Fetal responses to placental insufficiency: an update. BJOG 2004; 111: 1031-1041.
4. Cetin I, Alvino G: Intrauterine growth restriction: implications for placental metabolism and transport. A review. Placenta 2009; 30(Suppl A): S77-S82.
5. Lackman F, Capewell V, Richardson B, daSilva O, Gagnon R: The risks of spontaneous preterm delivery and perinatal mortality in relation to size at birth according to fetal versus neonatal growth standards. Am J Obstet Gynecol 2001; 184: 946-953.
6. Barker DJ: The long-term outcome of retarded fetal growth. Clin Obstet Gynecol 1997; 40: 853-863.
7. Benediktsson R, Lindsay RS, Noble J, Seckl JR, Edwards CR: Glucocorticoid exposure in utero: new model for adult hypertension. Lancet 1993; 341: 339-341.
8. Reinisch JM, Simon NG, Karow WG, Gandelman R: Prenatal exposure to prednisone in humans and animals retards intrauterine growth. Science 1978; 202: 436-438.
9. Phillips ID, Simonetta G, Owens JA, Robinson JS, Clarke IJ, McMillen IC: Placental restriction alters the functional development of the pituitary-adrenal axis in the sheep fetus during late gestation. Pediatr Res 1996; 40: 861-866.
10. Economides DL, Nicolaides KH, Campbell S: Metabolic and endocrine findings in appropriate and small for gestational age fetuses. J Perinat Med 1991; 19: 97-105.
11. Parker CR Jr, Buchina ES, Barefoot TK: Abnormal adrenal steroidogenesis in growth-retarded newborn infants. Pediatr Res 1994; 35: 633-636.
12. Stewart PM, Murry BA, Mason JI: Type 2 11 beta-hydroxysteroid dehydrogenase in human fetal tissues. J Clin Endocrinol Metab 1994; 78: 1529-1532.
13. Stewart PM, Rogerson FM, Mason JI: Type 2 11 beta-hydroxysteroid dehydrogenase messenger ribonucleic acid and activity in human placenta and fetal membranes: its relationship to birth weight and putative role in fetal adrenal steroidogenesis. J Clin Endocrinol Metab 1995; 80: 885-890.
14. Sun K, Yang K, Challis JR: Differential regulation of 11 beta-hydroxysteroid dehydrogenase type 1 and 2 by nitric oxide in cultured human placental trophoblast and chorionic cell preparation. Endocrinology 1997; 138: 4912-4920.
15. Rogerson FM, Kayes KM, White PC: Variation in placental type 2 11beta-hydroxysteroid dehydrogenase activity is not related to birth weight or placental weight. Mol Cell Endocrinol 1997; 128: 103-109.
16. Bro-Rasmussen F, Buus O, Trolle D: Ratio cortisone/cortisol in mother and infant at birth. Acta Endocrinol 1962; 40: 579-583.
17. Murphy VE, Zakar T, Smith R, Giles WB, Gibson PG, Clifton VL: Reduced 11beta-hydroxysteroid dehydrogenase type 2 activity is associated with decreased birth weight centile in pregnancies complicated by asthma. J Clin Endocrinol Metab 2002; 87: 1660-1668.
18. Dy J, Guan H, Sampath-Kumar R, Richardson BS, Yang K: Placental 11beta-hydroxysteroid dehydrogenase type 2 is reduced in pregnancies complicated with idiopathic intrauterine growth restriction: evidence that this is associated with an attenuated ratio of cortisone to cortisol in the umbilical artery. Placenta 2008; 29: 193-200.
19. McTernan CL, Draper N, Nicholson H et al: Reduced placental 11beta-hydroxysteroid dehydrogenase type 2 mRNA levels in human pregnancies complicated by intrauterine growth restriction: an analysis of possible mechanisms. J Clin Endocrinol Metab 2001; 86: 4979-4983.
20. Struwe E, Berzl GM, Schild RL et al: Simultaneously reduced gene expression of cortisol-activating and cortisol-inactivating enzymes in placentas of small-for-gestational-age neonates. Am J Obstet Gynecol 2007; 197: 43 e41-e46.
21. Shams M, Kilby MD, Somerset DA et al: 11Beta-hydroxysteroid dehydrogenase type 2 in human pregnancy and reduced expression in intrauterine growth restriction. Hum Reprod 1998; 13: 799-804.
22. White PC: 11beta-hydroxysteroid dehydrogenase and its role in the syndrome of apparent mineralocorticoid excess. Am J Med Sci 2001; 322: 308-315.
23. Alikhani-Koopaei R, Fouladkou F, Frey FJ, Frey BM: Epigenetic regulation of 11 beta-hydroxysteroid dehydrogenase type 2 expression. J Clin Invest 2004; 114: 1146-1157.
24. Ronco AM, Llaguno E, Epunan MJ, Llanos MN: Effect of cadmium on cortisol production and 11beta-hydroxysteroid dehydrogenase 2 expression by cultured human choriocarcinoma cells (JEG-3). Toxicol In Vitro 2010; 24: 1532-1537.
25. Marsit CJ, Maccani MA, Padbury JF, Lester BM: Placental 11-beta hydroxysteroid dehydrogenase methylation is associated with newborn growth and a measure of neurobehavioral outcome. PLoS One 2012; 7: e33794.
26. Murthi P, Fitzpatrick E, Borg AJ, Donath S, Brennecke SP, Kalionis B: GAPDH, 18S rRNA and YWHAZ are suitable endogenous reference genes for relative gene expression studies in placental tissues from human idiopathic fetal growth restriction. Placenta 2008; 29: 798-801.
27. Maccani MA, Marsit CJ: Epigenetics in the placenta. Am J Reprod Immunol 2009; 62: 78-89.
28. Bjornsson HT, Fallin MD, Feinberg AP: An integrated epigenetic and genetic approach to common human disease. Trends Genet 2004; 20: 350-358.
29. Lillycrop KA, Phillips ES, Torrens C, Hanson MA, Jackson AA, Burdge GC: Feeding pregnant rats a protein-restricted diet persistently alters the methylation of specific cytosines in the hepatic PPAR alpha promoter of the offspring. Br J Nutr 2008; 100: 278-282.
30. Katari S, Turan N, Bibikova M et al: DNA methylation and gene expression differences in children conceived in vitro or in vivo. Hum Mol Genet 2009; 18: 3769-3778.
31. Li LC, Carroll PR, Dahiya R: Epigenetic changes in prostate cancer: implication for diagnosis and treatment. J Natl Cancer Inst Jan, 19: 2005; 97: 103-115.